Table 1.
Overview of patient visits and MP cases.
| Visits | Totala | MP casesb | χ 2 c | P valuec |
|---|---|---|---|---|
| Five-year total | 29,558 | 10,039 | ||
| Breakdown by | ||||
| Year | 398.1 | <0.001 | ||
| 2019 | 5,252 (17.8%) | 1,402 (26.7%) | ||
| 2020 | 3,269 (11.1%) | 1,056 (32.3%) | ||
| 2021 | 7,196 (24.3%) | 2,830 (39.3%) | ||
| 2022 | 5,749 (19.4%) | 2,339 (40.7%) | ||
| 2023 | 8,092 (27.4%) | 2,412 (29.8%) | ||
| Age (years) | 1,654.5 | <0.001 | ||
| <1 | 1,582 (5.4%) | 66 (4.2%) | ||
| 1–2 | 4,544 (15.4%) | 981 (21.6%) | ||
| 3–5 | 11,936 (40.4%) | 3,758 (31.5%) | ||
| 6–15 | 11,474 (38.8%) | 5,234 (45.5%) | ||
| Month | 347 | <0.001 | ||
| Jan | 2,759 (9.3%) | 958 (34.7%) | ||
| Feb | 1,069 (3.6%) | 309 (28.9%) | ||
| Mar | 1,644 (5.6%) | 515 (31.3%) | ||
| Apr | 1,453 (4.9%) | 487 (33.5%) | ||
| May | 1,643 (5.6%) | 458 (27.9%) | ||
| Jun | 1,812 (6.1%) | 588 (32.5%) | ||
| Jul | 1,719 (5.8%) | 412 (24.0%) | ||
| Aug | 1,765 (6.0%) | 474 (26.9%) | ||
| Sep | 2,644 (8.9%) | 801 (30.3%) | ||
| Oct | 3,474 (11.8%) | 1,272 (36.6%) | ||
| Nov | 5,001 (16.9%) | 1,837 (36.7%) | ||
| Dec | 4,575 (15.5%) | 1,928 (42.1%) | ||
| Sex | 316.4 | <0.001 | ||
| Male | 16,205 (54.8%) | 4,783 (29.5%) | ||
| Female | 13,353 (45.2%) | 5,256 (39.4%) | ||
a
The percentage is calculated relative to the five-year total (n = 29,558).
b
The percentage is calculated relative to the total number of cases on the respective line.
c
Tests if the variation of the positivity rate with each group is statistically significant.